Xvivo Perfusion AB (publ) XVIVO.ST
XVIVO.ST
Xvivo Perfusion AB (publ) CEVI.ST
CellaVision AB (publ) SUS.ST
Surgical Science Sweden AB (publ) SECARE.ST
Swedencare AB (publ) IMP-A-SDB.ST
Implantica AG STIL.ST
Stille AB CRAD-B.ST
C-Rad AB (publ) BICO.ST
BICO Group AB (publ) PAX.ST
Paxman AB (publ) RAY-B.ST
RaySearch Laboratories AB (publ)
Xvivo Perfusion AB (publ) CEVI.ST
CellaVision AB (publ) SUS.ST
Surgical Science Sweden AB (publ) SECARE.ST
Swedencare AB (publ) IMP-A-SDB.ST
Implantica AG STIL.ST
Stille AB CRAD-B.ST
C-Rad AB (publ) BICO.ST
BICO Group AB (publ) PAX.ST
Paxman AB (publ) RAY-B.ST
RaySearch Laboratories AB (publ)
Performance
| Periode | XVIVO.ST | CEVI.ST | SUS.ST | SECARE.ST | IMP-A-SDB.ST | STIL.ST | CRAD-B.ST | BICO.ST | PAX.ST | RAY-B.ST |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -34.96 % | 19.11 % | -29.13 % | 12.52 % | 103.53 % | -7.58 % | 11.51 % | -37.94 % | -7.42 % | 0.65 % |
| YTD | -65.01 % | -11.58 % | -42.04 % | -16.08 % | 67.00 % | -8.88 % | 11.32 % | -31.64 % | -6.59 % | 4.04 % |
| 1Y | -63.55 % | -32.25 % | -27.66 % | 0.72 % | 39.71 % | -8.02 % | -9.97 % | -44.33 % | 0.65 % | 45.41 % |
| 3Y | 27.85 % | -37.35 % | -41.21 % | -10.11 % | 14.71 % | 59.84 % | -6.13 % | -39.51 % | 51.09 % | 331.90 % |
| 5Y | -25.52 % | -38.37 % | -0.87 % | -14.66 % | -34.43 % | 133.81 % | -18.84 % | -88.81 % | 133.71 % | 190.46 % |
| 10Y | 241.90 % | 268.47 % | 691.30 % | 1 023.61 % | -40.24 % | 1 150.00 % | 83.34 % | 64.26 % | 472.48 % | 120.48 % |
| Depuis le début | 844.74 % | 1 098.72 % | 691.30 % | 1 023.61 % | -40.24 % | 417.35 % | 131.31 % | 64.26 % | 472.48 % | 3 639.90 % |